Literature DB >> 29321710

Cytokine Polymorphism and HLA Genotyping in Patients with Temporal Lobe Epilepsy Related to Hippocampal Sclerosis.

Ayşe Altintaş1, Çiğdem Özkara1, Melis Sohtaoğlu Sevindik1, Mustafa Uzan2, Çiğdem Kekik Çinar3, Ömer Uysal4, Fatma Savran Oğuz3.   

Abstract

OBJECTIVE: Hippocampal sclerosis (HS) is the most common pathological substrate associated with mesial temporal lobe epilepsy (MTLE), where inflammatory processes are known to play an increasingly important role in the pathogenesis. To further investigate the role of the immune system, both cytokine gene polymorphisms and human leukocyte antigen (HLA) genotyping in patients with MTLE-HS were investigated.
METHODS: The DNA samples of 100 patients with MTLE-HS and 201 healthy individuals were genotyped for cytokines (IL-6,IL-10, TNF-α, TGF-β1 and IFN-γ) and HLA using polymerase chain reaction (PCR)-SSP and SSO methods. The results were statistically analyzed in patient and healthy control groups and then according to the presence of febrile seizures (FS) in the patient group.
RESULTS: Analysis of cytokine genotyping did not reveal any significant difference between patients with MTLE-HS and controls and patients with or without FS. However, the HLA DRB1*13 allele was found to be more frequent in the patient population after Bonferroni correction.
CONCLUSION: This study suggests the possible role of HLA in the pathogenesis of MTLE-HS, although it failed to show any relationship with the cytokine system. However, data regarding the role of HLA are still lacking, and further studies are necessary to verify our results.

Entities:  

Keywords:  HLA genotyping; Temporal lobe epilepsy; cytokine expression; hippocampal sclerosis

Year:  2016        PMID: 29321710      PMCID: PMC5758080          DOI: 10.5152/npa.2016.12678

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  43 in total

Review 1.  Cytokine gene polymorphism in human disease: on-line databases.

Authors:  J Bidwell; L Keen; G Gallagher; R Kimberly; T Huizinga; M F McDermott; J Oksenberg; J McNicholl; F Pociot; C Hardt; S D'Alfonso
Journal:  Genes Immun       Date:  1999-09       Impact factor: 2.676

Review 2.  Cytokine gene polymorphism in human disease: on-line databases, supplement 1.

Authors:  J Bidwell; L Keen; G Gallagher; R Kimberly; T Huizinga; M F McDermott; J Oksenberg; J McNicholl; F Pociot; C Hardt; S D'Alfonso
Journal:  Genes Immun       Date:  2001-04       Impact factor: 2.676

3.  An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia.

Authors:  N Laflamme; S Lacroix; S Rivest
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

4.  A fast method for high-quality genomic DNA extraction from whole human blood.

Authors:  S Gustincich; G Manfioletti; G Del Sal; C Schneider; P Carninci
Journal:  Biotechniques       Date:  1991-09       Impact factor: 1.993

Review 5.  Cytokines and blood-brain barrier permeability.

Authors:  A G de Boer; D D Breimer
Journal:  Prog Brain Res       Date:  1998       Impact factor: 2.453

6.  Soman-induced seizures rapidly activate astrocytes and microglia in discrete brain regions.

Authors:  L A Zimmer; M Ennis; M T Shipley
Journal:  J Comp Neurol       Date:  1997-02-24       Impact factor: 3.215

7.  Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels.

Authors:  J Peltola; J Laaksonen; A M Haapala; M Hurme; S Rainesalo; T Keränen
Journal:  Seizure       Date:  2002-01       Impact factor: 3.184

Review 8.  What is the cellular source of prostaglandins in the brain in response to systemic inflammation? Facts and controversies.

Authors:  S Rivest
Journal:  Mol Psychiatry       Date:  1999-11       Impact factor: 15.992

9.  Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis.

Authors:  Annamaria Vezzani; Daniela Moneta; Cristina Richichi; Marisa Aliprandi; Stephanie J Burrows; Teresa Ravizza; Carlo Perego; M Grazia De Simoni
Journal:  Epilepsia       Date:  2002       Impact factor: 5.864

10.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.